Effectiveness of Vasopressin During laparoscopic Hysterectomy

Effectiveness of Vasopressin During laparoscopic Hysterectomy - Vasopressin During laparoscopic Hysterectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020396

Enrollment

Registered

2016-01-01

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma uteri, adenomyosis

Interventions

Injection of dilute vasopressin solution to uterine myometrium injection of physiological saline solution to uterine myometrium

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women who have symptomatic uterine myomas and/or adenomyosis

Exclusion criteria

Exclusion criteria: 1. Patients with severe complications. 2. Laparoscopic hysterectomy for cervical myoma with a major diameter of more than 10 cm. 3. Patients who are judged to be inappropriate to carry out the study by the medical attendant.

Design outcomes

Primary

Measure	Time frame
Operation time, Blood loss.	—

Secondary

Measure	Time frame
Complications, duration of hospitalization.	—

Countries

Japan

Contacts

Public ContactFumiaki Taniguchi

Takanohara Central Hospital Department of Obstetrics and Gynecology

ftaniguc@gmail.com0742-71-1030

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026